Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension
November 6, 2025
[DOI] [PMC free article] [PubMed] [Google Scholar] 230.Rodriguez L.A., Finertie H., Neugebauer R.S., Gosiker B., Thomas T.W., Karter A.J., Gilliam L.K., Oshiro C., An J., Simonson G., et al
2 Therefore, the focus must be on using the medication period as a catalyst to build robust dietary patterns, consistent exercise routines, mindful eating skills, and healthy coping mechanisms that can support weight maintenance and overall health long after the medication's direct effects may have waned
GLP- 1 Receptor Agonists in Combination with Insulin The GLP- 1 receptor agonists have been shown to improve blood glucose control when used in conjunction with insulin, particularly basal insulin, and may be particularly useful in the treatment of advanced T2DM [108]
Wang JY, Wang QW, Yang XY, et al